NGS and multiomics, highly sensitive assay for cell free DNA, CTC capture and information analysis system enabled by magnetic nanoparticle technologies.
NVIGEN X™ is enabled by the state-of-the-art molecularly engineered nanoparticles, MagVigen™ and MyQuVigen™, to efficiently capture and identify molecular information from proteins, cells and nucleic acids. We are developing NVIGEN X™ into accurate, automated and FDA approved clinical instruments, assays and reagent kits deploy-able at hundreds and thousands of hospitals, turning fatal cancers into manageable diseases.
Multiomics and Highly Sensitive Biomarking Profiling for the Precision Curative Solution
From a single vial of whole blood sample, NVIGEN X™ applies the following streams of sample analysis:
- cfDNA Capture and Analysis
- CTC Capture and Phenotype
- Biomarker On-Beads ELISA Assay
- NGS and Multiomics profiling
Confirmative studies and further investigation with tissue or other biological samples and customized assays are also available.
- Aging and Neurodegenerative Diseases
- Complex Biomarker Research
- Single Cell or Intracellular Molecules
- Low Abundance & Rare Targets
|Gene Report Commercial Liquid Biopsy and MAF||CommercialTest Pre-Treatment (05/2021)||NVIGEN X™ Pre-Treatment, Concordance with the Commercial Test. 06/22/21||NVIGEN X™ Post-Treatment, Changes with Response 07/22/21|